Clarity progresses SECuRE trial with positive safety results
Clarity Pharmaceuticals Ltd has reported strong results from Cohort 4 of the SECuRE trial examining a treatment for prostate cancer
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.